<DOC>
	<DOC>NCT00073554</DOC>
	<brief_summary>This trial is for patients with acute occlusion of one of the arteries supplying blood to the leg. The trial is designed to determine the safety and activity of a novel clot dissolving (thrombolytic) drug (alfimeprase).</brief_summary>
	<brief_title>Alfimeprase for Thrombolysis in Acute Peripheral Arterial Occlusion</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<criteria>Patients with acute peripheral arterial occlusion of the lower limb (onset of symptoms within 14 days) Rutherford Class I or IIa (minimal sensory loss, no muscle weakness, audible venous flow) Age 18 or above Able to consent Able to follow up</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2006</verification_date>
</DOC>